ArticleAlzheimer's & dementia (New York, N. Y.)
Accelerometer-derived daily steps, cognition, and cognitive impairment in U.S. community-dwelling older adults: The Atherosclerosis Risk in Communities Study.
Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe relationship between daily steps and brain health is relatively underexplored, with inconsistent findings regarding the number of steps that confer cognitive benefits.
methodsWe conducted cross-sectional and longitudinal analyses using data from the Physical Activity and Falls Ancillary (PAFA) study of the Atherosclerosis Risk in Communities Study (ARIC) cohort. Participants wore an ActiGraph GT3X on the hip for ≥10 h on ≥3 days in 2016-2017. Daily step counts were analyzed continuously and categorically. Cognitive functioning and its change were assessed using global and domain-specific factor scores from a neuropsychological battery. Cognitive impairment was adjudicated (mild cognitive impairment [MCI] or dementia). Regression models-adjusted for demographics, lifestyle, and chronic conditions-evaluated differences in cognitive scores, their 4-year change, and odds of cognitive impairment by step counts. Spline terms assessed nonlinearity.
resultsAmong 430 participants (mean age, 78.4 years; 59.5% female; 19% Black), the baseline mean daily steps were 3492 (SD = 1934). In adjusted cross-sectional models, higher daily steps were associated with better global cognition and executive function/processing speed. Participants in the high-stepping group (≥4025 steps) had a 0.37-point higher executive function/processing speed score (95% confidence interval [CI]: 0.17-0.55) versus the low-step group (<2449). Those in the high-step group had 54% lower odds of prevalent cognitive impairment (odds ratio [OR] = 0.46, 95% CI: 0.24-0.89) compared with the lowest group. Spline models showed better cognition with higher steps, plateauing after ≈4000. Step counts were not associated with 4-year cognitive change. DISCUSSION: Higher daily step counts are associated with better cognitive function in older adults. Modest increases in activity, even among those who moved less (<4000 steps/day), may yield cognitive benefits, although reverse causation cannot be ruled out. Promoting achievable physical activity goals, such as step counts, could benefit older adults.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.